Aquestive Therapeutics, Inc. (AQST)
4.02
0.00 (0.00%)
USD |
NASDAQ |
May 29, 16:00
4.05
+0.03
(+0.75%)
After-Hours: 20:00
Aquestive Therapeutics EPS Diluted (Quarterly) : -0.0657 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.815 |
| Crinetics Pharmaceuticals, Inc. | -1.228 |
| Talphera, Inc. | -0.0366 |
| Harrow, Inc. | -0.7414 |
| Aytu Biopharma, Inc. | -0.5345 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.057M |
| Revenue (Quarterly) | 14.45M |
| Total Expenses (Quarterly) | 22.50M |
| Enterprise Value | 527.15M |
| Gross Profit Margin (Quarterly) | 75.99% |
| Profit Margin (Quarterly) | -55.77% |
| Earnings Yield | -15.00% |
| Normalized Earnings Yield | -15.00 |